Director, Global Market Access and Pricing, Immunology

Job Title: Director, Global Market Access and Pricing, Immunology

Location: Cambridge, MA

About the Job

Sanofi’s Immunology franchise has a diverse portfolio which includes the upcoming late-stage priority assets amlitelimab and lunsekimig, and early compounds at Proof-of-Concept or earlier stages of development. We are advancing a robust and growing pipeline of multiple indication assets that span a range of therapeutic areas including dermatology, asthma, gastroenterology, rheumatology, and many others.

The Global Market Access and Pricing (GMAP) lead will be responsible for access analytics and championing the one-voice market access perspective for pipeline assets throughout the development timeline. This will include providing market access input to support indication selection, clinical development plans at all stages, broader payer data generation efforts, forecasts, and governance meeting, while also developing top-line value messaging to support aspirations and pricing benchmarks.

This is a highly collaborative role that requires a strong cross-functional approach. The GMAP lead will be a core member of the Global Project Team and work closely with a range of functions and business partners (New Product Planning, Clinical, Medical, HEVA, Regulatory, HVT), as well countries where relevant, to fully realize the pricing and access potential of the portfolio.

The role will also entail improving early market access capabilities and planning across key assets in the pipeline through play-to-win behaviors.

We are an innovative global healthcare company, committed to transforming the lives of people with immune challenges, rare diseases and blood disorders, cancers, and neurological disorders. From R&D to sales, our talented teams work together, revolutionizing treatment, continually improving products, understanding unmet needs, and connecting communities. We chase the miracles of science every single day, pursuing progress to make a real impact on millions of patients around the world.

Main Responsibilities:

• Leads the assessment of various internal assets and potential target indications, in collaboration with the therapeutic global cross-functional partners

• Leads the development of the access and pricing strategy of internal assets, based on relevant scenarios developed in collaboration with New Product Planning

• Responsible for the timely development a clear Early Market Access Roadmap for all assets under scope to ensure the organization has the right level of understanding and preparedness to support decision making and market preparation

• Responsible for the timely execution of all core activities pertaining to the following:

• • Foundational knowledge of disease and payer unmet needs (through conducting secondary and primary payer research where relevant)

  • Early market access success factors / risks identification

  • Fact-based early potential assessments (with price/access assumptions for forecasting) and scenario development

  • Informed market access input to clinical development plan & pivotal trial design

  • Early market access plan

  • Early payer value proposition

  • Payer evidence plan and IEGP support, in partnership with HEVA, to ensure it supports the Payer Value proposition

• As part of the GPT and early commercialization team:

• • Contributes to the formulation and execution of the asset(s) strategy and ensure key payer/ market access considerations are made explicit and are addressed as appropriate (target patient population, clinical endpoints, comparator, etc)

  • Provides the relevant support for governance meetings (ie, TARC, DWG, IDCC, SPM, etc)

• Coordinates the relevant Market Access GLocal subteams, ensuring relevant input and engagement from priority markets

• Maintain a high level of knowledge with regards to the scientific, clinical, strategic pricing and commercial developments relevant to the assets under scope

• Develop and maintain a robust understanding of relevant pricing and reimbursement criteria used by payers in key markets to make informed decisions about payer strategy, plans and tactics

• Improves early market access capabilities across the pipeline thro